Metropolitan Life Insurance Company (MetLife)’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,382
Closed -$140K 1714
2024
Q1
$140K Sell
6,382
-348
-5% -$7.46K 0.01% 877
2023
Q4
$157K Hold
6,730
0.01% 858
2023
Q3
$133K Buy
6,730
+353
+6% +$6.95K 0.01% 872
2023
Q2
$145K Buy
+6,377
New +$128K 0.01% 825

Other funds holding RXO

Metropolitan Life Insurance Company (MetLife)'s RXO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of RXO (RXO) in Q2 2024, closing a stake of 6,382 shares — an estimated $140K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RXO in Q2 2023 and held it in 4 quarters. The position peaked at $157K in Q4 2023. 243 funds tracked by Wall St. Rank hold RXO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining RXO position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,382 RXO shares in Q2 2024, an estimated $140K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in RXO in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s RXO position peaked at $157K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held RXO as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.